87975-58-4

Upstream product

• 123-75-1 pyrrolidine 
• 1622-32-8 2-Chloroethanesulfonyl chloride 

Downstream Products

• 87975-64-2 Ethyl-[3-phenyl-2-(pyrrolidine-1-sulfonyl)-oxiranylmethyl]-amine 
• 87975-23-3 Benzyl-[2-bromo-2-(pyrrolidine-1-sulfonyl)-ethyl]-amine 
• 87975-48-2 1-(1-Benzyl-aziridine-2-sulfonyl)-pyrrolidine 
• 87975-22-2 [2-Bromo-2-(pyrrolidine-1-sulfonyl)-ethyl]-cyclohexyl-amine 
• 87975-47-1 1-(1-Cyclohexyl-aziridine-2-sulfonyl)-pyrrolidine 

Relevant academic research and scientific papers

Reactions of Aminoacetals with C-Nucleophiles as a New Method for the Synthesis of Di(het)arylmethane Derivatives with a Taurine Fragment

Abstract: Based on the acid-catalyzed reaction of functionalized aminoacetals with C-nucleophiles, a series of new diarylmethane derivatives with a taurine fragment were synthesized, the structure of which was established by NMR spectroscopy method.

Synthesis and Biological Evaluation of Taurine-Derived Diarylmethane and Dibenzoxanthene Derivatives as Possible Cytotoxic and Antimicrobial Agents

The series of novel taurine-derived diarylmethanes and dibenzoxanthenes was synthesized starting from simple commercially available precursors via modular three-stage approach. All the newly synthesized compounds were screened for in vitro antibacterial and antifungal activity, as well as cytotoxicity towards normal and cancer cell lines. Some of the synthesized compounds exhibited 2–4-fold higher activity against S. aureus, E. faecalis and B. cereus compared with Chloramphenicol. In contrast to Chloramphenicol, the tested compounds also showed bactericidal, rather than bacteriostatic effect, which makes them promising candidates for further studies.

PIPERIDINE COMPOUND AND PROCESS FOR PREPARING THE SAME

The present invention is to provide a piperidine compound represented by the formula [I]: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted benzene ring, R1 is hydrogen atom or a substituent for amino

MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND COMPOSITIONS AND METHODS RELATED THERETO

Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, X, R1, R2, R3, R4, and R5 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.